申请人:AKZO N.V.
公开号:EP0199393A1
公开(公告)日:1986-10-29
The invention relates to compounds of the general formula I
wherein
R1 represents one up to and including four, the same or different substituents selected from alkyl- (1-6 C), alkoxy(1-6 C), hydroxy, halogen, NO2, CF3 or the group -NR5R6,
whereby two substituents taken together may also represent a methylene-dioxy group,
X represents a member selected from
, -CH2-CH2-and -CH=CH-.
n has the value 0, 1 or 2,
R3 represents one of the moieties:
or
and R2, R4, Rs and R6 represent hydrogen or alkyl-(1-6C),
and pharmaceutically acceptable salts thereof, suitable in the treatment of heartfailure.
本发明涉及通式 I 的化合物,其中 R1 代表一个至四个(包括四个)相同或不同的取代基,这些取代基选自烷基(1-6C)、烷氧基(1-6C)、羟基、卤素、NO2、CF3 或基团 -NR5R6,其中两个取代基组合在一起还可代表亚甲基-二氧基,X 代表选自、-CH2-CH2 和 -CH=CH-的成员,n 的值为 0、1 或 2,R3 代表下列分子之一:或,R2、R4、Rs 和 R6 代表氢或烷基(1-6C),及其药学上可接受的盐,适用于治疗心衰。